Dr. Damiano Caruso of Sapienza Universita di Roma recounts how he got to know mint Lesion™ at a workshop hosted by the ESOI. Among other workstations, mint Lesion™ automatically stood out by being easy to use, practical, and “very consistent between the different timepoints of oncological examination.”
He describes how at their oncologic center, mint Lesion™ is used for clinical trials and for clinical routine, as the software provides them with standardized, structured reports which contain all necessary data needed for complex oncological cases.
The benefits of structured oncologic reporting with mint Lesion™
Related Resources
Related Resources
University Hospital Tuebingen: Study compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis
A study[1] conducted by researchers at University Hospital Tuebingen retrospectively compared the efficacy of two liver-targeted therapies,…
University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy
A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…
Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™
Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…